Does AZATHIOPRINE Cause Basal cell carcinoma? 349 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 349 reports of Basal cell carcinoma have been filed in association with AZATHIOPRINE (AZATHIOPRINE). This represents 1.1% of all adverse event reports for AZATHIOPRINE.
349
Reports of Basal cell carcinoma with AZATHIOPRINE
1.1%
of all AZATHIOPRINE reports
10
Deaths
193
Hospitalizations
How Dangerous Is Basal cell carcinoma From AZATHIOPRINE?
Of the 349 reports, 10 (2.9%) resulted in death, 193 (55.3%) required hospitalization, and 17 (4.9%) were considered life-threatening.
Is Basal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AZATHIOPRINE. However, 349 reports have been filed with the FAERS database.
What Other Side Effects Does AZATHIOPRINE Cause?
Drug ineffective (8,076)
Off label use (5,358)
Drug intolerance (3,392)
Condition aggravated (2,832)
Rheumatoid arthritis (2,746)
Treatment failure (2,483)
Arthralgia (2,427)
Drug hypersensitivity (2,421)
Nausea (2,178)
Pneumonia (2,157)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which AZATHIOPRINE Alternatives Have Lower Basal cell carcinoma Risk?
AZATHIOPRINE vs AZD-1222
AZATHIOPRINE vs AZELAIC ACID
AZATHIOPRINE vs AZELASTINE
AZATHIOPRINE vs AZELASTINE\FLUTICASONE
AZATHIOPRINE vs AZELNIDIPINE